Efficacy, safety and pharmacokinetics of a novel subcutaneous immunoglobulin, Evogam®, in primary immunodeficiency.
about
Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease.A Comparative Study of Intravenous Immunoglobulin and Subcutaneous Immunoglobulin in Adult Patients with Primary Immunodeficiency Diseases: A Systematic Review and Meta-Analysis.Cost-effectiveness analysis of subcutaneous immunoglobulin replacement therapy in Iranian patients with primary immunodeficiencies.Adverse Effects of Immunoglobulin Therapy.
P2860
Efficacy, safety and pharmacokinetics of a novel subcutaneous immunoglobulin, Evogam®, in primary immunodeficiency.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Efficacy, safety and pharmacok ...... , in primary immunodeficiency.
@en
Efficacy, safety and pharmacok ...... , in primary immunodeficiency.
@nl
type
label
Efficacy, safety and pharmacok ...... , in primary immunodeficiency.
@en
Efficacy, safety and pharmacok ...... , in primary immunodeficiency.
@nl
prefLabel
Efficacy, safety and pharmacok ...... , in primary immunodeficiency.
@en
Efficacy, safety and pharmacok ...... , in primary immunodeficiency.
@nl
P2093
P2860
P1476
Efficacy, safety and pharmacok ...... , in primary immunodeficiency.
@en
P2093
Constance H Katelaris
Darryl Maher
David Langton
Joanne Smart
John B Ziegler
Leon Rozen
Lisa K C Pearce
Marianne B Empson
Michael S Gold
Mimi L K Tang
P2860
P2888
P304
P356
10.1007/S10875-011-9641-4
P577
2012-04-13T00:00:00Z